Functionality of a novel follitropin alfa pen injector: results from human factor interactions by patients and nurses

References

• Papanikolaou EG, Kolibianakis E, Devroey P. Emerging drugs in assisted reproduction. Expert Opin Emerg Drugs. 2005;10:425–440.
   PubMedGoogle Scholar
• Macklon NS, Stouffer RL, Giudice LC, et al. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170–207.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Diedrich K, Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008;14:1–14.
   PubMed Web of Science ®Google Scholar
• Nelson SM, Yates RW, Lyall H, et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867–875.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, de Ziegler D, Howles CM, et al. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044–1051.
   PubMed Web of Science ®Google Scholar
• Allahbadia G. The Ideal Stimulation Protocol: Is There One? J Obstetrics Gynecol India. Nov–Dec 2015;65(6):357–361.
   Google Scholar
• Markle RL, King PJ, Martin DB. Characteristics of a successful human chorionic gonadotropin (hCG) administration in assisted reproduction. Fertility and Sterility. 2002;78(Suppl 1):S71–72.
   Google Scholar
• Howles CM, Saunders H, Alam V, et al. FSH Treatment Guidelines Clinical Panel. Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology(ART) procedures. An analysis of 1378 patients. Curr Med Res Opin. 2006;22:907–918.
   PubMed Web of Science ®Google Scholar
• Weiss N. Gonadotrophin products: empowering patients to choose the product that meets their needs. Reprod Biomed Online. 2007;15:31–37.
   PubMed Web of Science ®Google Scholar
• Schertz JC, Saunders H, Hecker C, et al. The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing. Expert Opin Drug Deliv. 2011;8:1111–1120.
   PubMed Web of Science ®Google Scholar
• Rama Raju GA, Suryanarayana K, Jaya PG, et al. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme – a retrospective study. J Clin Pharm Ther. 2008;33:401–407.
   PubMed Web of Science ®Google Scholar
• Huisman D, Raymakers X, Hoomans EH. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions. Reprod Biomed Online. 2009;19(Suppl 2):5–10.
   PubMedGoogle Scholar
• Sedbon E, Wainer R. Perves C Quality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in France. Reprod Biomed Online. 2006;12:298–303.
   PubMed Web of Science ®Google Scholar
• Namdar A, Naghizadeh MM, Zamani M, et al. Quality of life and general health of infertile women. Health Qual Life Outcomes. 2017;15:139.
   PubMed Web of Science ®Google Scholar
• Gameiro S, Boivin J, Peronace L, et al. Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment. Hum Reprod Update. 2012;18:652–669.
   PubMed Web of Science ®Google Scholar
• Cousineau TM, Domar AD. Psychological impact of infertility. Best Practice and Research. Clin Obstetrics Gynaecol. 2007;21:293–308.
   PubMed Web of Science ®Google Scholar
• Boivin J, Domar AD, Shapiro DB, et al. Tackling burden in ART: an integrated approach for medical staff. Hum Reprod. 2012;27:941–950.
   PubMed Web of Science ®Google Scholar
• FDA approved drug products. GONAL-f RFF. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
   Google Scholar
• Somkuti SG, Schertz JC, Moore M, et al. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women. Curr Med Res Opin. 2006;22:1981–1996.
   PubMed Web of Science ®Google Scholar
• Abbotts C, Salgado-Braga C, Audibert-Gros C. A redesigned follitropin alfa pen injector for infertility: results of a market research study. Patient Prefer Adherence. 2011;5:315–331.
   PubMed Web of Science ®Google Scholar
• Rettenbacher M, Andersen AN, Garcia-Velasco JA, et al. A multi-centre phase 3 study comparing efficacy and safety of Bemfola versus Gonal-f in women undergoing ovarian stimulation for IVF. Reprod Biomed Online. 2015;30:504–513.
   PubMed Web of Science ®Google Scholar
• Imthurn B, McVeigh E, Stiller R, et al. Evaluation of the use and handling of three different pen systems considered for in vivo fertilization treatment. Expert Opin Drug Deliv. 2014;11:1859–1864.
   PubMed Web of Science ®Google Scholar
• Quintero LA, Merino VV, Bitaine LDLF, et al. An evaluation by potential IVF/donor oocyte patients of the use and handling of the Bemfola® Pen compared with the Gonal-f® Pen and Puregon Pen® Revista Iberoamericana de Fertilidad y Reproducción Humana. 2016;33(3):42–51.
   Google Scholar
• Association for the Advancement of Medical Instrumentation (AAMI). Human factors design process for medical devices. Report No.: ANSI/AAMI HE 74. Arlington (VA): Association for the Advancement of Medical Instrumentation. 2001
   Google Scholar
• National Health Service. Design for patient safety: user testing in the development of medical devices. 2010. Available from: http://www.nrls.npsa.nhs.uk/resources/collections/design-for-patient-safety/?entryid45=74946
   Google Scholar
• Lewis JR. Sample sizes for usability studies: additional considerations. Human Factors. 1994;36:368–378.
   PubMed Web of Science ®Google Scholar
• Homburg R, Howles CM. Low-dose FSH therapy for an ovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum Reprod Update. 1999;5:493–499.
   PubMed Web of Science ®Google Scholar
• Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152:1423–1433.
   PubMed Web of Science ®Google Scholar
• Faller H. Shared decision making: an approach to strengthening patient participation in rehabilitation. Die Rehabilitation. 2003;42: 129–135. (in German).
   PubMedGoogle Scholar
• Teutsch C. Patient-doctor communication. Med Clin North Am. 2003;87:1115–1145.
   PubMed Web of Science ®Google Scholar